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Background: To understand neuronal molecular changes in senile diabetes we established a rat senile
diabetes model and analyzed transcriptome and proteome changes.
Methods: Wistar rats were fed a high sugar, high fat diet for 16 months to induce diabetes. Non-diabetic
aged rats and young rats were used as controls. Transcript and protein levels in the liver were then
analyzed by microarray and antibody arrays, respectively.
Results: Neuronal genes that were differentially expressed between senile diabetic rats, non-diabetic
aged rats, and young rats were distributed across 12 pathways and 23 Gene Ontology (GO) clusters.
Among them, 2267 genes were aging-related, 1230 genes were diabetes-associated, and 9 proteins might
be associated with neurological disorders.
Conclusion: In this study, we investigated transcriptome and proteome changes in animal models,
analyzed the impact of aging and diabetes on neuronal molecules, and conﬁrmed the correlations. Our
study provides support for further studies on mechanisms of neuronal diseases.
Copyright © 2016, Taiwan Society of Geriatric Emergency & Critical Care Medicine. Published by Elsevier
Taiwan LLC. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/
licenses/by-nc-nd/4.0/).1. Introduction
Growth in personal income and an increase in average life ex-
pectancy have contributed to a dramatic increase in the number of
older people with diabetes mellitus (DM) and associated compli-
cations, and the mortality rate in this group is much higher than in
the general population. Hyperglycemia causes signiﬁcant damagetial ﬁnancial or non-ﬁnancial
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es/by-nc-nd/4.0/).to the body through the accumulation of metabolic toxins such as
superoxides and advanced glycation end products, resulting in
ischemia, hypoxia, oxidative stress, and inﬂammation. It can also
cause apoptosis of neurons and gliosis, which may lead to cognitive
impairment and even central nervous system disorders such as
Alzheimer's disease (AD)1e3. Current studies have demonstrated
that multiple genes or proteins play important roles in diabetic
neuropathy, but there is a lack of data on transcriptome and pro-
teome changes in animal models used in research to investigate the
effects of on multiple genetic loci involved in nervous system
pathways.2. Materials and methods
2.1. Animal models
Eighty speciﬁc-pathogen-free (SPF) healthy female Wistar rats
(6 months of age, weighing 250 ± 20 g) were obtained commer-
cially. Animal experiments were approved by the Ethicsicine. Published by Elsevier Taiwan LLC. This is an open access article under the CC
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guidelines4. After feeding the rats for 7 days, animals were
randomly divided into 3 groups: 10 in the young group, 20 in the
aged group, and 50 in the senile diabetes group. Samples from the
rats in the young group were immediately prepared as described
in the next section. The aged group rats were fed a basic diet (ﬂour
19%, corn starch 23%, sorghum ﬂour 6%, bran 10%, skimmed milk
powder 20%, ﬁsh powder 10%, starch 7%, glycine 3%, and beer
yeast 2%). The senile diabetes group rats were fed a high fat, high
sugar diet (sugar 15%, lard 10%, cholesterol 4%, bile salt 0.3%, egg
yolk powder 10%, and basic diet 60.7%). The animals were fed
continuously for 16 months and the level of blood glucose was
monitored. If an animal did not become diabetic, i.e., did not have
a blood glucose level 16.7 mmoL/L characteristic of rats with
senile diabetes, a low dose of streptozotocin (STZ) (20 mg/kg) was
injected intraperitoneally. Three days later, the blood glucose level
was monitored again and animals with a high blood glucose level
were selected. The remaining animals received another intraper-
itoneal injection of STZ and qualiﬁed animals were selected after a
further 3 days.
2.2. Sample preparation
Rats in each group were weighed and anesthetized with 1%
urethane. The abdomen of each rat was then opened, and liver
tissues were collected and placed in liquid nitrogen for storage. To
obtain RNA for transcriptome analysis, 2 g of liver per animal wasFig. 1. Pie chart of biologicalobtained from 5 animals chosen at random in each group, and total
RNA was extracted from the liver samples using Trizol. For RNA
quality control, the value of the RNA integrity number (RIN)
measured by the Agilent 2100 Bioanalyzer had to be 7.0 and the
value of 28 S/18 S had to be 0.7.2.3. Microarray
Rat RNA and tissue samples were sent to the Shanghai
Biotechnology Corporation and analyzed using the Agilent Rat
Gene Expression 4  44 K Microarray Kit and the Full Moon Ex-
plorer Antibody Array.2.4. Bioinformatics
SAS software was used for bioinformatics analysis. Differences
between means of the 3 groups were analyzed by one-way
ANOVA. Differences between pairs of groups were analyzed by
Dunnett's test. A P value less than 0.05 was considered statistically
signiﬁcant. Fold change (FC) was calculated, and genes were
clustered by Gene Ontology (GO). The effects of aging and diabetes
on neuronal genes were analyzed by Pearson's c2 test. The P
values of genes in different signaling pathways were calculated by
Fisher's exact test. The genes in the resulted ﬁle were then cross-
checked and annotated with databases from NCBI Entrez Gene,
KEGG, and Biocarta.processes of the mRNA.
Table 1
The Gene Ontology of differentially expressed neuronal molecules.
Pathway name Hits Total Percent P
Alzheimer's disease 37 214 17.29% 0.0076
Amyotrophic lateral sclerosis (ALS) 22 66 33.33% 0.0343
Axon guidance 14 127 11.02% 0.0994
Cholinergic synapse 10 112 8.93% 0.3174
Huntington's disease 28 221 12.67% 0.0063
Long-term depression 8 71 11.27% 0.1679
Neuroactive ligand-receptor interaction 17 284 5.99% 0.8179
Neurotrophin signaling pathway 9 129 6.98% 0.6003
Olfactory transduction 140 1035 13.53% 0.0512
Parkinson's disease 21 167 12.57% 0.0174
Regulation of actin cytoskeleton 22 210 10.48% 0.0723
Taste transduction 4 50 8.00% 0.5051
We used the SAS system (SBC Analysis System) to do the annotation of the different
genes (http://www.ebioservice.com/sas.html) and all the pathway names came
from the KEGG database (http://www.kegg.jp/). P value was calculated by Fisher's
exact test.
Table 2
Statistical analysis of the effects of aging and diabetes on neuronal genes.
Neuronal genes Other genes Total c2 P
Aging 189 2078 2267 12.326 4.47 E-04
Diabetes 63 1167 1230
Total 252 3245 3497
Q. Xu et al.2143. Results
3.1. Differentially expressed mRNA
ANOVA analysis of the mRNAs revealed 5486 differentially
expressed genes (P < 0.05) that were clustered in 23 biological
processes (Fig. 1). The differentially expressed neuronal genes were
clustered to 12 pathways as shown in Table 1. As shown in Table 2,
2267 genes were associated with aging (aged group vs. young
group), and 1230 genes were associated with diabetes (senile dia-
betic group vs. aged group) (Tables 2e4).
3.2. Differentially expressed proteins
In all, 656 proteins were analyzed by the Explorer Antibody
Array, and each sample was repeated twice. Nine proteins associ-
ated with the nervous systemwere correlated with age or diabetes
(Fig. 2). All the differentially expressed proteins and their interac-
tive proteins are shown in Fig. 3.Table 3
Diabetes-related and differentially expressed rat neuronal genes.
Description Symbol
Cytoskeleton associated protein 2 Ckap2
Cell division cycle 2, G1 to S and G2 to M Cdc2
Cyclin B1 Ccnb1
Cyclin D1 Ccnd1
Neuronal pentraxin 2 Nptx2
Butyrylcholinesterase Bche
Olfactory receptor 428 Olr428
Neuropeptide FF receptor 1 Npffr1
Olfactory receptor 1583 Olr1583
Olfactory receptor 1096 Olr1096
Olfactory receptor 789 Olr789
GLIS family zinc ﬁnger 2 Glis2
Deleted in malignant brain tumors 1 Dmbt1
Triggering receptor expressed on Myeloid cells 2 Trem2
Gene Id denotes the ID number of the corresponding NCBI Entrez gene. FC ¼ expression
genes with FC > 2 or <0.5 between the senile diabetes and aged groups (P < 0.05).4. Discussion
Many researchers have recognized that obesity, hyperglycemia,
and hypercholesterolemia are risk factors for senile neuropathy,
especially neurodegenerative diseases such as AD and Parkinson's
disease (PD)5e9. Chronic high blood glucose can cause neuropathy
and microvascular disease, and induce vascular PD. Acute compli-
cations of diabetes such as ketoacidosis and nervous system dam-
age caused by hyperosmolar coma can lead to secondary
Parkinson's disease9. Results of epidemiological research are
controversial. Studies have shown that the risk of PD in patients
with DM was 40% higher than in non-DM patients, especially for
people who had had diabetes for more than 10 years (Odds
Ratio¼ 1.75)10. However, other studies showed that neither weight
nor waist circumference, both indicators of obesity associated with
risk for developing DM, was correlated with PD11.
Of the differentially expressed proteins that we identiﬁed, the
cadherin family of proteins plays an important role in development
of the nervous system. E-cadherin can inhibit differentiation and
promote migration of neural epithelial cells. E-cadherin expression
is low in multiple tumor tissues, including human squamous cell
esophageal cancer, nasopharyngeal carcinoma, thyroid carcinoma,
squamous cell head and neck cancers, malignant melanoma, breast
cancer, and retinoblastoma12e17. This study conﬁrmed that
expression of cadherin and E-cadherin was low in the aged and
senile diabetes groups, similar to results found in cancer research
studies.
Collagen IV (C-IV) is one of the main components of the base-
ment membrane. C-IV can promote cell adhesion, growth, and
differentiation18,19. Lein et al. found that C-IV could promote axon
growth, as well as increase the number and length of nerve ﬁbers20.
It is believed that C-IV functions through receptors in the mem-
brane of nerve cells to promote axon growth21. In this study,
expression levels of many cytoskeleton genes changed. In partic-
ular, expression levels of C-IV signiﬁcantly decreased in the aged
and senile diabetes groups compared to young rats.
Increased expression of ferritin (Fer) proteins is considered an
important and independent predictor of the development of DM.
Epidemiological studies indicate that an increased level of Fer in
serum is positively correlated with an increased incidence of
DM22e24. Upregulation or downregulation of Fer or the transferrin
receptor (Tfr) disrupts iron metabolism and leads to degenerative
diseases of the nervous system. In brain tumors, Tfr-induced
oxidation inhibits tyrosine phosphatase, activates mitogen-
activated protein kinase (MAPK) and Akt, inhibits cell cycle regu-
lators p21 and cyclin-dependent protein kinases (CDK), andGene Id Chromosome P FC
306575 16 0.0032 0.2282
54237 20 0.0379 0.2318
25203 2 0.0278 0.3403
58919 1 0.0455 0.3479
288475 12 0.0253 0.3823
65036 2 0.0267 0.3922
296689 3 0.0285 0.3956
64107 20 0.0044 0.4092
289241 13 0.0455 0.4514
302027 7 0.0310 0.4540
296042 3 0.0396 0.4944
302946 10 0.0378 2.1169
170568 1 2.00 E-04 2.7358
301227 9 0.0120 3.6642
of the senile diabetes group/expression of the aged group. This table lists neuronal
Table 4
Aging-related and differentially expressed rat neuronal genes.
Description Symbol Gene Id Chromosome P FC
Collagen, type IV, alpha 5 Col4a5 363457 X 5.00 E-04 0.1515
Transferrin receptor Tfr 64678 11 0.0016 0.1928
Collagen, type III, alpha 1 Col3a1 84032 9 0.0020 0.2332
Collagen, type I, alpha 2 Col1a2 84352 4 0.0061 0.3543
Odorant binding protein I f Obp1f 192267 X 0.0021 0.3859
Tubulin, alpha 4A Tuba4a 316531 9 0.0078 0.4764
Brain expressed myelocytomatosis oncogene Bmyc 311807 3 0.0046 2.0929
Deleted in malignant brain tumors 1 Dmbt1 170568 1 2.00 E-04 2.9055
Cytoskeleton associated protein 2 Ckap2 306575 16 0.0061 4.9598
Cholinergic receptor, nicotinic, alpha 7 Chrna7 25302 1 3.00 E-04 5.3270
Gene Id denotes the ID number of the corresponding NCBI Entrez gene. FC ¼ expression of the aged group/expression of the young group. This table lists neuronal genes with
FC > 2 or <0.5 between the aged groups and young groups (P < 0.05).
Neuronal Gene Analysis in Aged Rats 215promotes proliferation of tumor cells25. Restless legs syndrome
(RLS) may be caused by destabilization of Tfr1 mRNA, which may
decrease cellular uptake of iron26. When Tfr1 expression increases,
expression of amyloid precursor protein decreases, which slows the
progression of AD27. Our study found that expression of Tfr protein
in senile DM was signiﬁcantly increased, and conﬁrmed the cor-
relation between DM and the level of Fer protein. Compared with
the young group, Tfr mRNA expression in the aged group was
signiﬁcantly reduced, but the protein level was not obviously
different between the 2 groups, which suggests that translational
regulation controls Tfr protein levels during the aging process.Fig. 2. Expression levels of differentially expressed proteins. The expression level is the rel
difference between the aged and young groups (P < 0.05). #Indicates a signiﬁcant differencThe neurotrophic factor insulin can stimulate axonal growth
and promote regeneration of the peripheral nervous system, and is
required for survival of the sympathetic nervous system. In dia-
betic peripheral neuropathy, a lack of nervous system glucose
uptake caused by decreased insulin plays a major role28. Our
research suggested a similar injury; expression of insulin-like
growth factor-1 (Igf-1) protein was not signiﬁcantly different be-
tween the young and aged groups, but was signiﬁcantly reduced in
the senile diabetes group. However, Igf-1 mRNA transcripts were
not obviously different, which suggest that regulation is at the
translation level.ative expression of proteins normalized to the control b-actin. *Indicates a signiﬁcant
e between the senile diabetes and aged groups (P < 0.05).
Fig. 3. Interactions of differentially expressed proteins. STRING is a database of predicted functional associations among genes/proteins (http://www.bork.embl-heidelberg.de/
STRING/). This is the conﬁdence view. Stronger associations are represented by thicker lines. The red spheres in the pictures represent the differentially expressed proteins. A.
Cltc-clathrin. B. Cdh-cadherin C. CDH1-cadherin 1, cadherin-E. D. Col4a2 e collagen, type IV, alpha 2. E. Tfrc-transferrin receptor protein 1. F. Syp e Synaptophysin. G. Igfr1-Insulin-
like growth factor I. H. Cald1-caldesmon 1. I. Atm-ataxia telangiectasia mutated.
Q. Xu et al.216The physiological role of synaptophysin (Syn) is not completely
understood, but it is thought to play roles in synaptic vesicle
exocytosis and Ca2þ-dependent neurotransmitter release, synaptic
vesicle recycling, and synapse formation29,30. In senile diabetic rats,
the expression of Syn was signiﬁcantly reduced, which suggests a
direct role in diabetic neuropathy.
The mRNA levels of many olfactory receptors including ol-
factory receptor 789 and olfactory receptor 1096 weredownregulated in senile diabetic rats, but protein levels were not
obviously changed. Olfactory receptors belong to a large family in
the genome, and many receptors in this family were affected.
Impaired olfaction reﬂects initial nervous system damage, but
the mechanism is not clear. This study also found that levels of
mRNA and protein expression were not correlated, which sug-
gests that they are regulated at transcriptional and translational
levels.
Neuronal Gene Analysis in Aged Rats 2175. Conclusions
The pathogenesis of diseases begins with molecular changes at
the micro level and progresses to phenotypic changes at the macro
level. We propose that themechanism bywhich traditional Chinese
medicine improves the health of the nervous system in senile
diabetes acts via regulation of multiple targets and multiple path-
ways, as suggested both by animal experiments and by clinical
observations in patients. This study provides a molecular basis for
the prevention and early diagnosis of DM and senile neurological
diseases. The roles of the genes, proteins, and signaling pathways
that are affected require further veriﬁcation and study.
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